That is essential, due to the fact that the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has been an experimental process (biotech stocks). But now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development practically nobody saw. But it's going to have profound implications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of financial investment opportunities in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (artificial intelligence). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially prior to going higher - biotech stock. I've been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly informing readers. However that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. black sea. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic personal companies on the brink of hitting the general public markets And I've been working on a brand-new way for you to invest even prior to these business go public.
This chance has actually been constructing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to schedule your area for complimentary.
Emma Walsh here, managing editor of the Journal. Routine Diary readers understand that tech isn't our typical beat (jeff brown 2021 stock predictions). And when it concerns tech investing, we leave it to the specialists. Thankfully, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we know (genetic sequencer stock jeff brown). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential development and developing extraordinary chances for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. self-driving cars. But despite what numerous readers may think, this is a pattern that's simply beginning. Even though the COVID-19 pandemic interrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (second wave). Losing two months of manufacturing and sales actually affects the number of 5G gadgets are sold in the calendar year. When you consider all of that, offering 250 million systems is remarkable. More notably, the delays triggered by the pandemic created a lots of bottled-up need. And that demand is now going to be pressed into 2021. In fact, I forecast that more than 500 million 5G devices will be shipped in 2021 - biotech stocks jeff brown. And that's not my only 5G forecast When I've spoken about 5G in the past, I have actually explained its 3 various phases.
In Phase 2, 5G devices go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services begin to be provided (jeff brown top biotech 2020). That's when we start to see applications working on 5G networks. Consider things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer season. This begins something of a virtuous cycle: The majority of people don't really care about the innovation. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The investment chances going forward will be massive. Stepping far from 5G, the next essential technology I anticipate in 2021 is CRISPR hereditary editing. CRISPR stands for "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not function correctly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For several years, CRISPR was mostly a niche innovation that wasn't well understood. And during that time, there were actually only three companies running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This entire market is efficiently a greenfield opportunity.
There's room for many business to exist in this area. tech predictions. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can precisely anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is essential due to the fact that the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has been an experimental process. And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however several drug therapies produced utilizing this technology. This was among those advancements that almost nobody saw. But it's going to have profound ramifications for curing illness. And, of course, there will be lots of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back maybe considerably prior to going greater. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever released was on bitcoin - artificial intelligence. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. diplomatic relations. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, however we could not individually validate this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like ability to select winning innovation stocks. He spent more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an outstanding viewpoint on the marketplace. He's constantly on the hunt for new opportunities, and he shares much of his best choices in the Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively forecasted a few of the most significant financial events of the previous 20 years. Although he does not appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it best each time, but Jeff Brown's accurate forecasts have earned him legions of dedicated followers. That says a lot about his capability. The Future Report is released by Brownstone Research, a popular financial research publisher. Brownstone Research study provides a number of research study services with a variety of specializations - democratic republic.
The company is also connected with Bonner & Partners, another well-respected research publisher - jeff brown predictions for 2021. On its site, Brownstone states its objective is to provide retail investors with professional-grade research study: "For too long, the very best investment research has not been available to private financiers. It has been typically reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. future report review. The objective of Brownstone Research study is to make that sort of proprietary research available to any financiers seeking to acquire an edge in the marketplaces. The objective is basic to provide unique and profitable financial investment research found no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After years of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you know even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown 2021 stock predictions. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. exponential tech investor. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding 2 advanced technologies: synthetic intelligence and electric vehicles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing brief of the automobile industry's Holy Grail. As you understand, electrical cars and self-driving automobile stocks have actually been big this year, but the Wall Street maker has actually approved hype without much concrete outcome. Despite a drastic increase in competitors over the past couple of years, Brown still believes Musk has the very best opportunity of putting everything together.
tech might be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transport. Generally, this technology would permit you to lease out your automobile as a self-governing, self-driving taxi when you're not utilizing it. You merely get out of the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you understand, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the earnings. It sounds crazy, but it could be closed than you think.